首页> 美国卫生研究院文献>Radiology and Oncology >Postoperative Radiotherapy for Patients with Completely Resected Pathological Stage IIIA-N2 Non-small Cell Lung Cancer: A Preferential Benefit for Squamous Cell Carcinoma

【2h】

Postoperative Radiotherapy for Patients with Completely Resected Pathological Stage IIIA-N2 Non-small Cell Lung Cancer: A Preferential Benefit for Squamous Cell Carcinoma

机译：术后放疗患者全切除病理学阶段IIIA-N2非小细胞肺癌：鳞状细胞癌的优先效益

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

The beneficial effect of postoperative radiotherapy (PORT) on completely resected pathological IIIA-N2 (pIIIA-N2) non-small cell lung cancer (NSCLC) has been a subject of interest with controversy. The aim of the study was to distinguish the clinical efficacy of PORT on lung adenocarcinoma (LADC) and lung squamous cell carcinoma (LSCC) among pIIIA-N2 NSCLC.

机译：术后放射治疗（港口）对完全切除的病理IIIA-N2（PIIIA-N2）非小细胞肺癌（NSCLC）的有益效果一直是争议的兴趣主题。该研究的目的是区分PIIIA-N2 NSCLC中肺腺癌（LADC）和肺鳞状细胞癌（LSCC）对肺腺癌（LADC）的临床疗效。

著录项

期刊名称 Radiology and Oncology
作者
Cuimeng Tian; Guimei Liu; Yongxiang Xu; Guangrong Xia; Tongmei Zhang; Jiaqiang Huang; Hui Jiang; Ji Ming Wang; Dr. Baolan Li;
展开▼
作者单位

展开▼
年(卷),期 2021(55),1
年度 2021
页码 66–76
总页数 11
原文格式 PDF
正文语种
中图分类肿瘤学;
关键词
lung squamous cell carcinoma; lung adenocarcinoma; pIIIA-N2; postoperative radiotherapy;

机译：肺鳞状细胞癌;肺腺癌;piiia-n2;术后放疗;

相似文献

外文文献
中文文献
专利

1. Simple OS Risk Score Classification in Resected Pathological Stage IIIA-N2 Non-Small Cell Lung Cancer Patients before Postoperative Radiotherapy: A Prediction Model [J] . Deng L., Hui Z., Men Y., International Journal of Radiation Oncology, Biology, Physics . 2019,第1Suppla期

机译：切除病理学阶段IIIA-N2非小细胞肺癌患者的简单OS风险分类分类：预测模型
2. P2.14-017 Postoperative Radiotherapy in Completely Resected Stage IIIA-N2 Non-Small Cell Lung Cancer [J] . S. Ahn, K. Na, Y. Kim, Journal of thoracic oncology: official publication of the International Association for the Study of Lung Cancer . 2017,第11期

机译：P2.14-017术后放疗完全切除阶段IIIA-N2非小细胞肺癌
3. Selection of proper candidates with resected pathological stage IIIA-N2 non-small cell lung cancer for postoperative radiotherapy [J] . Hui Zhouguang, Dai Honghai, Liang Jun, Thoracic cancer. . 2015,第3期

机译：病理切除IIIA-N2期非小细胞肺癌的合适候选人的选择
4. FDG uptake as a biological prognostic factor for recurrence in patients with surgically resected stage Ⅰ non-small cell lung cancer [C] . The First China-Japan-Korea conference of nuclear medicine . 2002

机译：手术切除的Ⅰ期非小细胞肺癌患者FDG摄取是复发的生物学预后因素
5. The cost effectiveness of screening for early stage lung cancer and the testing and treatment of molecular subgroups among non-small cell lung cancer patients in the province of ontario, canada [D] . Thao, Mallory. 2014

机译：加拿大安大略省非小细胞肺癌患者早期肺癌筛查的成本效益及分子亚群的检测和治疗
6. Early postoperative radiotherapy is associated with improved outcomes over late postoperative radiotherapy in the management of completely resected (R0) Stage IIIA-N2 non-small cell lung cancer [O] . Huan-Huan Wang, Lei Deng, Qing-Lian Wen, 2017

机译：在完全切除（R0）IIIA-N2期非小细胞肺癌的治疗中术后早期放疗与术后晚期放疗相比可改善结局
7. Postoperative radiotherapy for patients with completely resected pathological stage IIIA-N2 non-small cell lung cancer: focusing on an effect of the number of mediastinal lymph node stations involved [O] . H. Matsuguma, R. Nakahara, Y. Ishikawa, 2008

机译：完全切除病理学阶段IIIA-N2非小细胞肺癌术后放疗：专注于所涉及的纵隔淋巴结站数量的效果

Postoperative Radiotherapy for Patients with Completely Resected Pathological Stage IIIA-N2 Non-small Cell Lung Cancer: A Preferential Benefit for Squamous Cell Carcinoma

摘要

著录项

相似文献

相关主题

期刊订阅